Dmg Group, LLC Liquidia Corp Call Options Transaction History
Dmg Group, LLC
- $126 Million
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding LQDA
# of Institutions
201Shares Held
47.1MCall Options Held
475KPut Options Held
527K-
Black Rock Inc. New York, NY4.24MShares$102 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.24MShares$102 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.59MShares$86.6 Million0.0% of portfolio
-
Findell Capital Management LLC New York, NY2.89MShares$69.6 Million20.5% of portfolio
-
Opaleye Management Inc. Boston, MA2.26MShares$54.5 Million9.17% of portfolio
About Liquidia Corp
- Ticker LQDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,362,300
- Market Cap $1.55B
- Description
- Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...